
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Epidemiology, University of California-Los Angeles School of Public Health, and Jonsson Comprehensive Cancer Center, Los Angeles, California 90095-1772 [V. W. S., Z-F. Z., C-J. T., D. C.]; Biostatistics and Epidemiology Service, New York Eye and Ear Infirmary, New York, New York 10003 [G-P. Y.]; School of Public Health, Columbia University, New York, New York 10032 [Y-L. L.]; Department of Pathology [M-L. L.] and Gastroenterology and Nutrition Service, Department of Medicine [R. C. K.], Memorial Sloan-Kettering Cancer Center, New York, New York 10021; Yangzhong County Anti-Epidemic Station, Yangzhong County 212200, Peoples Republic of China [M-R. W., C. H. G.]; Department of Epidemiology, School of Public Health, Shanghai Medical University, Shanghai 200032, Peoples Republic of China [S-Z. Y.]
Glutathione S-tranferase (GST) enzymes are involved in
detoxification of many potentially carcinogenic compounds. The
homozygous deletions or null genotypes of GSTT1
(
class) and GSTM1 (µ class) genes may be
associated with an increased risk of cancer. Few studies have evaluated
the relationship between GSTT1, GSTM1 and the risk of
gastric cancer, as well as the potential interactions between these
genetic markers and other risk factors of gastric cancer in the Chinese
population. We conducted a case-control study with 143 cases with
gastric cancer, 166 chronic gastritis (CG) cases and 433 cancer-free
population controls from Yangzhong County, China. The
epidemiological data were collected by a standard questionnaire for all
of the subjects, and blood samples were obtained from 91 gastric cancer
cases, 146 CG cases, and 429 controls. GSTT1 and
GSTM1 genotypes were assayed by the PCR method, and
Helicobacter pylori infection was measured by the ELISA
method. Using logistic regression model in SAS, we assessed the
independent effects of GSTT1 and GSTM1
null genotypes on the risk of gastric cancer and their potential
interactions with other factors. The prevalence of GSTM1
null genotype was 48% in gastric cancer cases, 60% in CG patients,
and 51% in controls. The prevalence of GSTT1 null
genotype was 54% in gastric cancer cases, 48% in CG patients, and
46% in controls. After controlling for age, gender, education,
pack-years of smoking, alcohol drinking, body mass index, H.
pylori infection, and fruit and salt intake, the adjusted odds
ratio (OR) for GSTT1 and gastric cancer was 2.50 (95%
confidence interval (CI), 1.016.22). When gastric cancer cases were
compared with CG patients, the adjusted OR for GSTT1 was
2.33 (95% CI, 0.757.25). However, GSTT1 null genotype
was not associated with the risk of CG when using population controls.
No obvious association was found between GSTM1 and the
risk of both gastric cancer and CG. Our results suggest that
GSTT1 null genotype may be associated with an increased
risk of gastric cancer in a Chinese population.
This article has been cited by other articles:
![]() |
A. Agudo, N. Sala, G. Pera, G. Capella, A. Berenguer, N. Garcia, D. Palli, H. Boeing, G. Del Giudice, C. Saieva, et al. Polymorphisms in Metabolic Genes Related to Tobacco Smoke and the Risk of Gastric Cancer in the European Prospective Investigation into Cancer and Nutrition Cancer Epidemiol. Biomarkers Prev., December 1, 2006; 15(12): 2427 - 2434. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Boccia, G. La Torre, F. Gianfagna, A. Mannocci, and G. Ricciardi Glutathione S-transferase T1 status and gastric cancer risk: a meta-analysis of the literature Mutagenesis, March 1, 2006; 21(2): 115 - 123. [Abstract] [Full Text] [PDF] |
||||
![]() |
W.-c. You, J.-Y. Hong, L. Zhang, K.-f. Pan, D. Pee, J.-y. Li, J.-l. Ma, N. Rothman, N. Caporaso, J. F. Fraumeni Jr., et al. Genetic Polymorphisms of CYP2E1, GSTT1, GSTP1, GSTM1, ALDH2, and ODC and the Risk of Advanced Precancerous Gastric Lesions in a Chinese Population Cancer Epidemiol. Biomarkers Prev., February 1, 2005; 14(2): 451 - 458. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. C. Morari, J. L. P. Leite, F. Granja, L. V. M. da Assumpcao, and L. S. Ward The Null Genotype of Glutathione S-Transferase M1 and T1 Locus Increases the Risk for Thyroid Cancer Cancer Epidemiol. Biomarkers Prev., November 1, 2002; 11(11): 1485 - 1488. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Geisler and A. F. Olshan GSTM1, GSTT1, and the Risk of Squamous Cell Carcinoma of the Head and Neck: A Mini-HuGE Review Am. J. Epidemiol., July 15, 2001; 154(2): 95 - 105. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Lan, X. He, D. J. Costa, L. Tian, N. Rothman, G. Hu, and J. L. Mumford Indoor Coal Combustion Emissions, GSTM1 and GSTT1 Genotypes, and Lung Cancer Risk: A Case-Control Study in Xuan Wei, China Cancer Epidemiol. Biomarkers Prev., June 1, 2000; 9(6): 605 - 608. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |